Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Alset AI Announces Trading on the OTCQB Venture Market in the United States and 10-for-1 Share Consolidation to Enhance Shareholder Value
-
TVBuddy Smart TV Remote App Review: I Ditched My Physical Remote for 30 Days
-
Investor Frenzy: APEMARS Skyrockets as Top Crypto To Watch Now With ROI While Dogecoin and Snek Hold Steady
-
Palvella Therapeutics Announces Scientific Publication in Journal of Vascular Anomalies Highlighting the Infiltrative Growth and Therapeutic Challenges of Microcystic Lymphatic Malformations
-
SEED Therapeutics Announces Poster Presentation at AACR Annual Meeting 2026
-
Soluna Reports Record 2025 Growth: Pipeline Hits 4.3GW, Raises $142 Million, and Launches AI Infrastructure
-
Veradermics Reports Fourth Quarter and Full Year 2025 Financial Results and Highlights Recent Corporate and Clinical Updates
-
Marvel Biosciences Secures Alberta Innovates Funding to Support the Phase I Testing of MB-204
-
PHINIA Inc. to Report Q1 2026 Earnings
-
Capstone Expands Commercial Market Reach with KLAD Integration, Unlocking High-Margin, Asset-Light Revenue Growth
-
Drilling intersects 92.6 metres (m) of 0.95 g/t gold
-
Sensei Biotherapeutics Reports Full Year 2025 Financial Results and Provides Corporate Update
-
ProCap Financial Stockholders Approve Acquisition of AI Agent Lab CFO Silvia
-
Canopy Growth’s Apollo Cannabis Clinics Named Best Medical Cannabis Clinic
-
BTQ Technologies to Host Live Webinar on 2025 Financial Results and General Corporate Update
-
BeyondSpring Announces Plinabulin and ADC Combination Poster Presentation at AACR Annual Meeting 2026
-
Neurolief Secures Additional $6 Million Investment Following FDA Approval of Proliv™Rx, Expanding Access to Brain Neuromodulation Therapy for Patients with Inadequate Response to Antidepressants
-
AGNICO EAGLE PROVIDES NOTICE OF RELEASE OF FIRST QUARTER 2026 RESULTS, CONFERENCE CALL AND ANNUAL MEETING
-
Jack in the Box Inc. Announces Katelyn Zborowski as Chief Marketing Officer
-
Cass Commercial Bank Names Eric Giering President
-
InflaRx Highlights Clinical Activity of Vilobelimab in Pyoderma Gangrenosum in Late-Breaker Oral Presentation at 2026 American Academy of Dermatology Annual Meeting
-
Bitfarms to Participate in Jefferies Fireside Chat
-
FDA Approves New High Dose Regimen of SPINRAZA® (nusinersen) for Spinal Muscular Atrophy
-
Bombardier Announces Extension of Consent Solicitation with Respect to its 7.35% Debentures due 2026
-
BridgeBio Submits NDA to FDA for BBP-418 for Individuals Living with LGMD2I/R9
-
BullFrog AI Announces Commercial Agreement with Top 5 Global Pharmaceutical Company to Identify and Prioritize Therapeutic Target in Major Depressive Disorder
-
Medicus Pharma Reports KOL Validation of SkinJect Phase 2 Data of 80% Overall Response Rate
-
Bicara Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
-
Marimaca Announces the Appointment of Zenon Wozniak to its Board of Directors; Giancarlo Bruno appointed Independent Non-Executive Chair; Board Changes
-
Anavex Life Sciences Provides Comprehensive Regulatory Update
-
Aehr Test Systems to Announce Third Quarter Fiscal 2026 Financial Results on April 7, 2026
-
Sol-Millennium Medical Inc. Launches U.S. B2B eShop, Providing Direct Access to Safety Engineered Medical Devices Nationwide
-
Capitalzodiac Unveils "Geo-Matrix" – A Revolutionary Analytical Framework for the Global Strategic Minerals Sector
-
Capitalzodiac Unveils "Geo-Matrix" – A Revolutionary Analytical Framework for the Global Strategic Minerals Sector
-
NEURONES: Declaration of transactions on treasury shares (March 23 to 27, 2026)
-
Alterity Therapeutics Receives Positive FDA Feedback Following Type C Meeting on ATH434 Phase 3 Program
-
DriverAI Mileage Tracking App Review: Smart Automation That Actually Works
-
Can-Fite’s Partner Vetbiolix Completes Enrollment in Phase 2 Osteoarthritis Study in Dogs Treated with Piclidenoson; Data Expected in Q3 2026
-
Appili Therapeutics to Exhibit at World Vaccine Congress Washington
-
BLUENERGIES ANNOUNCES TRADING ON OTCQX BEST MARKET UNDER THE TRADING SYMBOL "BLUGF"
-
Royalty Pharma Announces R&D Funding Collaboration for Chronic Immune-Mediated Diseases
-
Nicus to Spotlight AI-Driven IT Financial Management at 2026 ITFMA Annual Conference
-
Bausch + Lomb Will Release First-Quarter 2026 Financial Results on April 29
-
Royalty Pharma Announces R&D Funding Collaboration for Chronic Immune-Mediated Diseases
-
Bayport Management Ltd Standalone Financial Statements year ended December 2025
-
Advocating for Awareness: RHA Celebrates Developmental Disabilities Awareness Month
-
Sasol Financing USA LLC Announces the Commencement of Cash Tender Offers for Outstanding Debt Securities and New Senior Notes Offering
-
New Analyses: EPA Consistently Fails to Warn Public of Pesticide Cancer Risks
-
Sound Seal Adds Two Regional Sales Managers to Support U.S. Growth
-
KLDC Expands Multi-Phase Gold System and Secures OJEP Funding

